dpp4i and glp 1 agonist GLP-1 receptor agonists or DPP-4 inhibitors: How to guide the clinician? GLP-1 Agonists and DPP-4 Inhibitors

They offer real, life-changing benefits for manyyet come with side effects, high costs, and long-term uncertainties

The most commonly reported side effects of GLP-1 medications are gastrointestinal symptoms like nausea, abdominal pain, and constipation

The recommended SAXENDA daily dose is 3 mg, with a gradual dose escalation starting at 0.6 mg per day and increasing weekly to minimize side effects

The effect of semaglutide on drinking habits and drinking relapse also was not tested in the male mice

Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis mediated by weight loss: findings from the Shanghai Osteoarthritis Cohort

[DOI] [PMC free article] [PubMed] [Google Scholar] 623.Ceriello A., De Nigris V., Pujadas G., La Sala L., Bonfigli A.R., Testa R